PRKAA1 and hyperinsulinemic hypoglycemia, familial, 4: Thus, we used two pharmacological AMPK signaling inhibitors, compound C and SBI-0206965 that act on the activation loop of AMPK α-subunit,32,33 to examine the possible effects of AMPK signaling on βγ-CAT regulation under cell nutrient deficiency.